 |
|
Maximum: 8 CME cr.
0 new discussion posts (35 published)
Sign in to view your progression
|
The intermediate to experienced level surgeons is an exclusive opportunity to learn from and listen to the most experienced European surgeons. Advanced course in Fertility Sparing Management of Gynaecological Cancers addresses very special aspects that effect fertility and fertility preservation in young patients with gynaecological cancers.
The course aims to improve the training of surgeons and elevate the standards of knowledge on management of surgical aspects of gynaecological cancers treatment across Europe through hands-on training.
Improve knowledge and skills in the indications and limits of fertility sparing strategies in gynecological cancers
Acquire comprehensive update on different types of conservative treatments and fertility preserving procedures in cervical, endometrial and ovarian tumors
Understand how to select patients for fertility preserving procedures and how different surgical steps for the conservative surgeries
Obtain first hand knowledge from theoretical lectures and filmed surgery to enhance your experience
The ideal profile of the course candidate is an experienced gynaecological oncologist with special interest in the reproductive and fertility aspects of cancer treatment, aiming to refine their advanced surgical skills especially in the aspect of fertility sparing surgery. Candidates should be fluent in the English language.
Listed below are the potential conflict of interest, as disclosed by the speakers.
Tom Bourne
Grants/research supports: Samsung Medison
Honoraria or consultation fees: Samsung Medison, GE Healthcare
Christina Fotopoulou
Honoraria or consultation fees: Roche, AZ, Sequana, Ethicon
Richard Smith
Spouse/partner: [to update]
The remaining faculty reported no conflict of interest.
|
Lecture 1 - Ultrasound: how can the IOTA rules differentiate pelvic masses to direct surgical radicality? Comparison to MRI features
|
|
|
Lecture 2 - How has the definition and characterization of Borderline tumor definition evolved over time?
|
|
|
Lecture 3: Ideal imaging prior to trachelectomy for early cervical cancer: how to exclude high risk patients?
|
|
|
References & Assessment | Session 1 - Diagnostic pathways and patients
|
|
|
Lecture 4 - Conservative treatment options for complex atypical hyperplasia and early invasive cancer: how safe is it to wait?
|
|
|
Lecture 5 - Ovarian conservation in endometrial cancer and uterine sarcomas
|
|
|
Lecture 6 - Uterine transplantation in cancer patients
|
|
|
References & Assessment | Session 2 - Endometrial cancer
|
|
|
Lecture 7: Preoperative patients consultation for 2-stage procedure and theatre planning
|
|
|
Lecture 8: Minimal invasive surgery in early ovarian cancer: is it safe not to open?
|
|
|
Lecture 9: Fertility sparing approach in low grade and borderline lesions
|
|
|
Lecture 10: Safety of assisted reproductive options in patients with epithelial and non epithelial ovarian neoplasms
|
|
|
References & Assessment | Session 3 - Ovarian cancer and Borderline tumors
|
|
|
Lecture 11: Trachelectomy versus cone? Is less enough after all?
|
|
|
Lecture 12: Trachelectomy in pregnancy
|
|
|
Lecture 13: Fertility options and reserves after pelvic radiotherapy.
|
|
|
References & Assessment | Session 4 - Cervical Cancer
|
|
|
Lecture 14: Sexuality and psychooncological support in young women with cancer
|
|
|
Lecture 15: Fertility reserves after cytotoxic chemotherapy for gynaecological cancers and how to reduce toxicity
|
|
|
Lecture 16: Treatment of gynae cancers during pregnancy
|
|
|
Lecture 17: What is the optimal management in fertility preservation in stage IB1 cervical cancer > 2 cm
|
|
|
Lecture 18: Neoadjuvant chemotherapy in advanced cervical cancers to preserve fertility? Is this safe?
|
|
|
References & Assessment | Session 5 - Psychooncological care and follow up
|
|
|
Evaluation & Certificate
|
|
